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Abstract 
Aims: This study evaluated the antibiotic-induced changes in microbial ecology, intestinal 
dysbiosis and low-grade inflammation; and the combined effect of four different 
Lactobacillus species on recovery of microbiota composition and improvement of gut barrier 
function in mice. 
Methods and Results: Administration of the antibiotic ampicillin for 2 weeks decreased 
microbial community diversity, induced caecum tumefaction and increased gut permeability 
in mice. Application of a probiotic cocktail of four Lactobacillus species (JUP-Y4) 
modulated the microbiota community structure and promoted the abundance of potentially 
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beneficial bacteria such as Akkermansia. Ampicillin administration led to a decline in 
Bacteroidetes from 46.6±3.91% to 0.264±0.0362%; the addition of JUP-Y4 restored this to 
41.4±2.87%. This probiotic supplementation was more effective than natural restoration, 
where the levels of Bacteroidetes were only restored to 29.3%±2.07%. Interestingly, 
JUP-Y4 treatment was more effective in the restoration of microbiota in faecal samples than 
in caecal samples. JUP-Y4 also significantly reduced the levels of D-lactate and endotoxin 
(lipopolysaccharide, LPS) in the serum of mice, and increased the expression of 
tight-junction proteins while reducing the production of inflammatory cytokines (TNF-α, 
IL-6, MCP-1, IFN-γ and IL-1β) in the ileum and the colon of antibiotic-treated mice. 
Conclusions: JUP-Y4 not only promoted recovery from antibiotic-induced gut dysbiosis, but 
also enhanced the function of the gut barrier, reduced inflammation, and lowered levels of 
circulating endotoxin in mice. 
Significance and Impact of Study: Consumption of a mixture of Lactobacillus species may 
encourage faster recovery from antibiotic-induced gut dysbiosis and gut microbiota-related 
immune disturbance. 
 
Keywords: antibiotics; Lactobacillus; intestinal microbiota; immunology; diseases 
 
Introduction 
Antibiotics have been used as medical therapies for almost 100 years, with considerable 
benefits to healthcare and improved survival rates of patients with previously intractable 
microbial infections. The medical use of antibiotics, especially broad-spectrum ones such as 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
ampicillin, has increased drastically worldwide. Epidemiological studies show a relationship 
between the overuse of antibiotic and an increased risk of dysbiosis and inflammatory 
diseases (Cho et al. 2012; Canova et al. 2014; Goulet 2015). Furthermore, recent animal 
studies have confirmed that antibiotic exposure can induce gut microbiome alterations that 
ultimately affect host metabolic and inflammatory responses associated with inflammatory 
bowel disease (IBD), irritable bowel syndrome (IBS), necrotizing enterocolitis, and chronic 
diarrhoea (Fouhy et al. 2012; Cox et al. 2014; Nobel et al. 2015), as well as extra-intestinal 
disorders such as type 2 diabetes, food allergy, asthma and obesity (Swidsinski et al. 2008b; 
Tannock 2008; De et al. 2010). 
Several animal studies and human clinical trials have demonstrated the protective effects 
of dietary supplements comprised of particular strains of probiotic Lactobacillus, against gut 
diseases including antibiotic-associated diarrhoea (AAD) and Clostridium difficile infection 
(CDI) (Mileti et al. 2009; Gao et al. 2010; Gareau et al. 2010; Kale-Pradhan et al. 2010; Zhu 
et al. 2011). For example, L. casei strain ATCC334, inhibited the progression of colon cancer 
by mediating apoptosis through the c-Jun N-terminal kinase pathway (Konishi et al. 2016). 
Consumption of L. plantarum was reported to alleviate the side effects of antibiotic therapy, 
including the risk of nausea and developing loose or watery stools (Lonnermark et al. 2010). 
Furthermore, administration of L. rhamnosus and L. helveticus prevented microbial dysbiosis 
in an IBD mouse model (Emge et al. 2016). However, to date there have been few studies on 
the protective effects achieved using a combination of different lactic acid bacteria against 
antibiotic-induced alterations in intestinal microbiota and inflammation; this is despite the 
fact that the benefits of using mixtures of probiotics against other conditions, have been well 
documented (Jernberg et al. 2007; Buffie et al. 2012; Brown et al. 2017). 
It is increasingly evident that many fermented foods contain live bacteria some of which 
are genetically similar to strains used as probiotics (Marco et al. 2017), and there is evidence 
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that Lactobacillus strains isolated from fermented foods can provide health benefits 
(Rousseaux et al. 2007). The aim of this study was to evaluate the effectiveness of a mixture 
of four Lactobacillus species on restoration of gut microbiota and regulation of immunity in 
mice following treatment with antibiotic. 
 
Material and Methods 
Culturing of bacteria 
The strains of Lactobacillus species used in this experiment were isolated from Chinese 
traditional fermented foods and included: L. plantarum CCFM2602 and L. casei CCFM2710 
isolated from a yogurt-like dairy product from Inner Mongolia; L. rhamnosus CCFM492 
obtained from pickled Chinese cabbage; and L. helveticus CCFM671 isolated from fermented 
camels’ milk from Xinjiang. All strains were held in long-term storage (at -80°C in 30% 
sterile glycerol) in the Culture Collection of the Food Microbiology (CCFM) of Jiangnan 
University. Prior to use the four strains described above were cultured in de Man Rogosa and 
Sharpe (MRS) broth at 37°C overnight without shaking. The bacterial cultures were 
centrifuged and the pellets re-suspended in 0.9% saline solution and mixed in equal volumes 
(the concentration of each strain was adjusted to 0.5 × 10
9
 CFU per 0.2 mL using the plate 
counting method), to give a final concentration of 2 × 10
9
 CFU per 0.2 mL. The mixture of 
the four Lactobacillus strains was designated as Jiangnan University Probiotic-Ying 4 strains 
(JUP-Y4). 
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Animal experiments 
The experimental protocol was approved by the Ethics Committee of Jiangnan University, 
Wuxi, China (JN No. 201501671), and every effort was made to minimise animal suffering. 
Four-week-old male C57BL/6J mice were purchased from Shanghai Slack Experimental 
Animal Co., Ltd. (China) and maintained in a designated pathogen-free facility.  
After a one-week acclimatisation period, the mice were randomly allocated into two groups 
(Table 1): the Control group (Cont; n=6) which were fed a regular diet (ad libitum) 
throughout the experimental period and a second group of mice (n=18) that all received 
ampicillin (500 mg kg
-1
) via oral gavage twice-daily for 14 days. After this modelling period, 
the mice in the second group were randomly allocated into three sub-groups (n=6 per group) 
as follows: the Ampicillin group (Amp) which was sacrificed (at 14 d); the Natural 
Restoration (NatR) group which received 0.9% saline solution (0.2 mL) via oral gavage for 4 
weeks in addition to regular diet; and the Probiotics group (JUP-Y4) which received 2 × 10
9
 
CFU (0.2 mL per dose) of JUP-Y4 preparation (in saline) via oral gavage for 4 weeks in 
addition to regular diet. 
Throughout the experiment, the weight of each mouse was recorded twice weekly, and faecal 
samples were collected after 7, 14 and 28 days. Blood (0.5-1.5 mL) from each mouse was 
collected into anticoagulant tubes after sacrifice. At the end of the experiment, the remaining 
mice were sacrificed (both NatR and JUP-Y4 groups, at 14 d+4 weeks) and tissues, including 
the colon, caecum (and its contents) and ileum, were excised and frozen immediately in 
liquid nitrogen before further analysis. To collect the faeces, the mice were placed in a sterile 
room and wiped lightly using 75% alcohol. Then fresh faecal samples were collected and 
transferred into sterile precooled tubes, and then stored at -80 °C. 
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DNA extraction and 16S rRNA gene sequencing 
Total genomic DNA was extracted from the faecal samples and also the contents of the 
caecum using the FastDNA Spin Kit for Soil (MP Biomedical, USA) according to the 
manufacturer’s instructions. The V4 region of the bacterial 16S rRNA gene was amplified 
from each sample with a forward (5’-AYT GGG YDT AAA GNG-3’) and reverse (5’-TAC 
NVG GGT ATC TAA TCC-3’) primer set and using the conditions described by Zhao et al. 
(2013). After purification, the PCR products were quantified using a Quant-iT PicoGreen 
dsDNA Assay Kit (Life Technologies, USA). Libraries were prepared using the TruSeq DNA 
LT Sample Preparation Kit (Illumina, USA) and analysed on a MiSeq sequencer platform 
with the MiSeq Reagent Kit (500 cycles-PE, Illumina). 
 
Bioinformatics analysis 
Following removal of sequencing primers and barcode trimming, the sets of sequences that 
shared identity (>97%) were defined as operational taxonomic units (OTUs). These OTUs 
were assigned using the Ribosomal Database Project (RDP) Naive Bayes classifier (Wang et 
al. 2007). Representative sequences from each cluster identified were aligned using the 
PyNAST aligner to the green genes core set in QIIME (Caporaso et al. 2010), which was also 
used to calculate alpha and beta diversity and rarefaction curves. The Shannon diversity index 
was estimated to evaluate the ecological diversity of the microbiota in each sample. 
Similarity between the microbial communities was determined using a UniFrac analysis 
(Lozupone and Knight 2005). 
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Enzyme-linked immunosorbent assays (ELISAs) of blood and tissues 
Blood samples were each centrifuged at 3,000 g for 10 min. The sera were each mixed with 
limulus lysate reagent to evaluate endotoxin (lipopolysaccharide, LPS) levels (P D Cani 
2009), and an enzymatic assay kit was used to determine D-lactate concentrations (Chen et 
al. 2012). Ceca, ilea and colon tissue samples were each homogenised with a Scientz-50 
tissue mill (Lanzhi, Ningbo, China). The resulting homogenates were centrifuged twice at 
13,000 g for 10 min and the supernatants were transferred to fresh tubes. The levels of 
tumour necrosis factor alpha (TNF-α), monocyte chemotactic protein 1 (MCP-1), 
interleukin-6 (IL-6) and interferon-γ (IFN-γ) were determined using specific ELISA kits 
following the manufacturer’s instructions (Nanjing SenBeiJia Biological Technology Co. 
Ltd. China). 
 
Real-time RT-PCR 
RNA was extracted from colon and ileal tissue samples using TRIzol reagent (Ambion, USA) 
and reverse transcribed into cDNA using a Reverse Transcriptase kit following the 
manufacturer’s instructions (TaKaRa, Japan). Gene expression was determined on a real-time 
quantitative PCR system (CFX Connect; Bio-Rad), using appropriate primers and iTaq 
Universal SYBR green Supermix (Bio-Rad, USA). Primer sets utilised for the determination 
of the gene expression of TNF-α were (forward 5-TAG CCA GGA GGG AGA ACA GA-3 
and reverse 5-TTT TCT GGA GGG AGA TGT GG-3), IL-1β (forward 5-TTG AAG AAG 
AGC CCA TCC TC-3 and reverse 5-CAG CTC ATA TGG GTC CGA C-3), MCP-1 
(forward 5-TCA CTG AAG CCA GCT CTC TCT-3 and reverse 5-GTG GGG CGT TAA 
CTG CAT-3), IFN-γ (forward 5-CGG TGA GAA GAT GTT CCA TGC CAC-3 and reverse 
5-TCT CCT TCA GGA CAA TGT CAA ACA-3). Relative quantification of the target gene 
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was analysed using normalisation with the β-actin gene (forward 
5-GGCTGTATTCCCCTCCATCG-3 and reverse 5-CCAGTTGGTAACAATGCCATGT-3) 
and calculated according to the 2
-ΔΔCT
 method (Livak and Schmittgen 2001). 
 
Statistical analysis 
A one-way analysis of variance (ANOVA) and a Tukey’s post hoc test were performed, and 
95% confidence intervals were used. The analyses were performed using SPSS software 
(version 16.0; SPSS Inc., USA). Comparisons between different groups were achieved using 
the two-tailed student’s t test (*P < 0.05 and **P < 0.01; GraphPad Prism version 5.00). 
Differences were considered significant at a P value < 0.05. Data are presented as means ± 
standard deviation (SD). 
 
Results 
Impact of a mixture of Lactobacillus strains on antibiotic-induced intestinal physiology 
Compared with the Cont group, antibiotic treatment (Amp group) significantly increased the 
caecal weight, as indicated by the caecum index (caecum weight/mouse weight) (P<0.01, 
Figure 1). Caecal tumidity was still severe in NatR group where the caecum index was also 
significantly higher than the Cont group (P<0.01). However, in the JUP-Y4 treatment group, 
the caecum index was reduced to the same level as that in the control group. Gut permeability 
was indicated by the levels of endotoxin and D-lactate in the serum, which increased in the 
antibiotic group but decreased at a faster rate following JUP-Y4 treatment compared with the 
NatR group. (Figure 2). The expression of intestinal epithelial tight-junction proteins, 
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including ZO-1, occludin and claudin-1, in the ileum and caecum segments was inhibited 
after antibiotic exposure but restored by the use of JUP-Y4 (Figure 3). 
 
JUP-Y4 restores diversity of the gut microbiota in mice with antibiotic-induced dysbiosis 
The calculated Shannon diversity index value (Figure 4A) indicated that antibiotic exposure 
significantly reduced gut microbial diversity in the Amp mice group. The final diversity 
index values in the NatR group (4.52±0.20) were lower than both that of the Cont group 
(5.98±0.38) and the JUP-Y4 group, the latter of which had the highest diversity value of 
6.56±0.26. 
The abundance matrix obtained from faecal samples was subjected to an unweighted UniFrac 
PCoA, which clearly separated the Amp group from the Cont group. The JUP-Y4 and NatR 
groups were distributed in between the other two groups (Figure 4B). Clustering of the group 
means, which was based on the Mahalanobis distances derived from PCoA scores, confirmed 
a statistically significant separation between the microbiota from the Cont, Amp, NatR and 
JUP-Y4 groups with the position of the JUP-Y4 group being much closer to the Cont group 
than the NatR group (Figure 4C). In summary, treatment with the probiotic, JUP-Y4, shifted 
the overall structure of the antibiotic-disrupted gut microbiota toward that of the Cont group. 
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Changes in the key phylotypes of gut microbiota are reversed by JUP-Y4 treatment after 
antibiotic exposure 
Gut microbiota analysis at the phylum level 
After antibiotic exposure, the gut microbiota in both the faeces and caecum were largely 
dominated by Proteobacteria (Figure 5). In faeces, the abundances of Firmicutes and 
Bacteroidetes were restored following treatment with JUP-Y4 to values more similar to those 
in the Cont group than in the NatR group (Figure 5A). In caecal samples, the phylum-level 
structure of the gut microbiota was even more disordered in the NatR group, where 
Firmicutes accounted for 61.5 ± 2.6% compared with 26.8 ± 5.7% in the Cont group (Figure 
5B). The treatment with JUP-Y4 helped to decrease the relative levels of Firmicutes to 42.2 ± 
5.3% which was still higher than the Cont group, reflecting the contribution of the added 
Lactobacillus species to the overall abundance of Firmicutes. 
 
Gut microbiota analysis at the genus level 
At the genus level, antibiotic treatment significantly increased the abundances of 
Staphylococcus, Acinetobacter, Azorhizophilus, Enterococcus and Pseudomonas relative to 
the Cont group in faeces, whereas the abundances of other genera decreased (Figure 6). In 
faecal samples, the JUP-Y4 treatment enriched the populations of Akkermansia, Alistipes and 
Porphyromonadaceae while reduced the abundances of Desulfovibrionales, Anaerotruncus, 
Sporobacter, Robinsoniella, Oscillibacter, Dorea, Ruminococcus, Clostridia and 
Helicobacter compared with the NatR group. Accordingly, the levels of these genera in the 
JUP-Y4 group were closer to the levels in the Cont group than levels in the NatR group. A 
cluster analysis in a heat map (Figure 6) indicated that treatment with JUP-Y4 restored the 
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gut microbiota structure and abundance to levels similar to those in the Cont group, whereas 
the NatR group struggled to reach the same levels following antibiotic treatment. 
Results from caecal samples were consistent with results from faecal samples; the 
abundances of Acinetobacter, Burkholderia, Pseudomonas, Betaproteobacteria, 
Proteobacteria and Enterococcaceae increased in response to antibiotic use, whereas other 
genera decreased (Figure 7). However, in the case of the caecal samples, restoration of the 
microbiota following JUP-Y4 treatment was not different to that in the NatR mice cohort. 
 
Consumption of a mixture of Lactobacillus species (JUP-Y4) improves immune function 
in the intestines of antibiotic-exposed mice 
Antibiotic administration influenced intestinal immune cell homeostasis, the protein levels of 
TNF-α, IL-6, MCP-1 and IFN-γ were significantly higher in the colon and ileal tissues of 
antibiotic-exposed mice compared with the Cont treatment (Figure 8). Notably, levels of 
these inflammatory cytokines were reduced by varying degrees in the JUP-Y4 treatment 
compared with the NatR group. 
The expression of specific cytokines at the mRNA level was also determined. The transcript 
levels of TNF-α, IL-1β, MCP-1 and IFN-γ increased significantly in the colon and ilea of 
antibiotic-treated mice compared with the Cont group (Figure S1). However, expression of 
these transcripts was reduced more following treatment with JUP-Y4, than in the NatR group. 
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Discussion 
In this study, we used a mouse model of antibiotic exposure that exhibited significant 
alterations in intestinal bacterial communities and immune cell homeostasis. We observed 
that treatment with a cocktail of Lactobacillus species (JUP-Y4; containing L. plantarum, L. 
casei, L. rhamnosus and L. helveticus) derived from fermented foods restored the gut 
microbiota community structure, enhanced microbial diversity and reduced the intestinal 
inflammation caused by antibiotic administration. 
It is noteworthy that there was a difference in the gut microbiota from faecal and caecal 
samples in the present study, as indicated by the more effective restoration of gut microbiota 
by JUP-Y4 in the former than the latter. Previous studies have also shown differences 
between the composition of caecal and faecal microbial communities in mice (Pang et al. 
2012; Gu et al. 2013). A report by Tanca et al. (2017) indicated that taxon-specific functions, 
oxalate degradation and glutamate metabolism varied between microbiota communities from 
caecal and faecal samples. The beneficial modulatory effects of treatment with a cocktail of 
Lactobacillus species following antibiotic exposure were greater in microbiota from faecal 
samples than microbiota from caecal samples, implying that the probiotic cocktail was more 
effective in the colon than in the caecum. 
A single dose of antibiotic is sufficient to induce gut microbiota dysbiosis (Knoop et al. 
2016). In susceptible hosts, these antibiotic treatments could trigger intestinal dysbiosis and 
systemic bacterial translocation (Sartor and Balfour 2008; Shaw et al. 2010; Shaw et al. 
2011). A previous study also showed that commensal bacteria affected the expression of host 
genes associated with mucosal barrier function, xenobiotic metabolism and nutrient 
absorption (Hooper et al. 2001). These antibiotic-induced subclinical intestinal abnormalities 
favour the expansion of opportunistic microbes, enhance inflammatory responses and 
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ultimately lead to the development of chronic diseases, although in this study we did not 
study the antibiotic treatment in the context of any specific disease. Serum D-lactate and 
endotoxin levels were measured as markers of gut permeability (Bischoff et al. 2014). 
Several pathologies including gastrointestinal diseases and metabolic syndrome have been 
linked to alteration of intestinal barrier function and permeability of the gut epithelium, (Sun 
et al. 2001; Camilleri et al. 2012). In our study, we have demonstrated that the antibiotic 
administration to mice increased the levels of serum D-lactate and endotoxin. 
The mechanisms accounting for the protective effect of JUP-Y4 against intestinal dysbiosis 
may be attributed to three aspects: modulation of the gut microbiota community structure; 
promotion of beneficial bacteria; and activation of the host-adaptive immune system. The 
composition of the intestinal microbiome fluctuated for two weeks in response to the 
administration of oral antibiotics. At both phylum and genus level, the structure and 
abundance of gut microbiota could be restored by the use of our cocktail JUP-Y4. The 
JUP-Y4 probiotic treatment promoted beneficial bacteria, and these oligosaccharides and 
short-chain fatty acids producing bacteria can stimulate microbial interactions, the hosts 
immune responses, and metabolic signalling (Derrien et al. 2011). 
In the present study, antibiotic-induced changes in the gut microbiota were better restored by 
treatment with the JUP-Y4 cocktail than via natural recovery. We observed that it was 
difficult to reduce the abundance of some opportunistic pathogenic bacteria, including 
Desulfovibrionales, Clostridia and Helicobacter during natural recovery. However, probiotic 
treatment decreased the abundance of Desulfovibrionales, which are associated with Crohn’s 
disease (Chiodini et al. 2015) and human infections such as appendicitis and cholecystitis 
(Swidsinski et al. 2008a; Kaakoush et al. 2012). In addition, the abundances of some 
beneficial bacteria, such as Akkermansia species, increased to higher levels following 
probiotic treatment than during natural recovery. Akkermansia species are thought to be 
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biomarkers for intestinal health (Swidsinski et al. 2011) and their abundance is inversely 
correlated with the severity of Crohn’s disease, ulcerative colitis (Png et al. 2010), 
appendicitis, obesity (Santacruz et al. 2010) and paediatric autism (Wang et al. 2011). 
Moreover, the microorganisms isolated from fermented food could alter the composition and 
function of the intestinal microbiota, although the significance of these changes and their 
importance to probiotic efficacy is under debate (van Hylckama Vlieg et al. 2011; 
Kato-Kataoka et al. 2016). In this study, we have showed the JUP-Y4 is able to modulate the 
microbiota more effectively after antibiotic-induced disturbance. 
Antibiotic-exposed mice are known to produce higher levels of pro-inﬂammatory cytokines, 
including TNF-α, IL-6, MCP-1 and IFN-γ in intestinal tissues than the untreated mice (Suzaki 
et al. 1999; Knoop et al. 2016). In this study, we also detected increases in the levels of these 
four cytokines following ampicillin treatment. The application of JUP-Y4 decreased 
intestinal inflammation in antibiotic-treated mice with associated reductions in levels of all 
four cytokines when quantified either at the protein level or by transcription analysis. In 
another study a strain of L. paracasei was also able to downregulate the expression of the 
IL-6 and TNF-α in neomycin-administered mice which suffered from Crohn’s disease (Verdú 
2006). Furthermore, some probiotics have been shown to activate anti-inflammatory 
mechanisms and regulate mucosal immune responses (Gareau et al. 2010). For example, L. 
casei DN-114001 attenuated pathogenic activation of the pro-inflammatory signal 
transduction cascade by inhibiting the NF-κB signal transduction pathway (Tien et al. 2006). 
In other hand, the tight junction integrity could strengthen the intestinal barrier, thus limiting 
the ability of antigens to enter the body and prevent adverse immune responses. L. plantarum 
MB452 up-regulated the expression of four tight junction proteins (occludin, ZO-1, ZO-2 and 
cingulin) and some proteasome-associated genes in Caco-2 cells, which indicated protection 
of intestinal barrier function by this probiotic (Anderson et al. 2010). L. plantarum 
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CCFM8610 (Zhai et al. 2016) reversed disruption of tight junctions, alleviated inflammation 
and decreased intestinal permeability in mice with chronic cadmium exposure. Similarly, L. 
rhamnosus GG ameliorated chronic alcoholic liver disease by positively modulating intestinal 
tight junctions via miR122a regulation (Zhao et al. 2015). In such antibiotic-induced mice, 
mucosal inflammation and various aspects of immune function have been influenced either 
directly or indirectly by the gut microbial signal. The mixture of Lactobacillus species in 
JUP-Y4 reported in this study improved tight junction integrity of the intestinal epithelial 
cells.  
 
In summary, antibiotic-induced changes in the development or composition of the gut 
microbiota and intestinal barrier integrity can disturb the relationship between the microbiota 
and the host immune system, eventually leading to altered immune responses, which may 
underlie multiple host inflammatory disorders. The ability of JUP-Y4 to modulate 
antibiotic-induced gut dysbiosis is reflected in the restoration of the gut microbiota and 
intestinal barrier, suggesting the potential for this probiotic mixture to restore gut homeostasis 
much faster than by natural restoration after the cessation of antibiotic treatment. Although 
the translation of these outcomes to clinical practice needs further clinical research, probiotic 
interventions intended to selectively promote bacteria could become an important dietary 
strategy to enhance recovery from dysbiosis and related immune disturbances associated with 
antibiotic use. 
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Table 
Table 1 Animal experimental protocol 
Group Acclimatisation 
for 7 days 
Antibiotic model assay 
for 14 days 
Lactobacillus therapy assay 
for 28 days 
Control (Cont) Regular diet 0.9% saline solution 0.9% saline solution 
Ampicillin (Amp) Regular diet Ampicillin (500 mg 
kg-1) 
Sacrificed 
Natural Restoration (NatR) Regular diet Ampicillin (500 mg 
kg-1) 
0.9% saline solution 
Mixture of Probiotics 
(JUP-Y4) 
Regular diet Ampicillin (500 mg 
kg-1) 
Lactobacillus species 
A cocktail of Lactobacillus species was administered to mice via gavage in 0.9% saline 
solution. Equal volumes of 0.9% saline solution (0.2 mL) were administered to the 
non-treatment group (Cont). 
 
Figure Legends 
Figure 1 Administration of a mixture of Lactobacillus species (JUP-Y4) attenuates 
antibiotic-induced caecum tumefaction.  
The caecum index was calculated as: caecum weight (g)/mouse weight (g). Control (Cont) 
indicates the Non-treatment group, Ampicillin (Amp) indicates oral gavage with ampicillin 
(500 mg kg
-1
) for 2 weeks, Natural restoration (NatR) indicates oral gavage with 0.9% saline 
solution for 4 weeks after ampicillin gavage, and JUP-Y4 indicates oral gavage with a 
Lactobacillus cocktail (L. plantarum CCFM2602, L. casei CCFM2710, L. rhamnosus 
CCFM492 and L. helveticus CCFM671) for 4 weeks after gavage with ampicillin. Data are 
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shown as means ± standard deviations. Two-tailed student’s t test determined statistical 
significance, **P < 0.01 and ns means no significant difference. n = 6 mice per group 
Figure 2 Administration of a mixture of Lactobacillus species (JUP-Y4) mitigates 
antibiotic-induced gut barrier dysfunction. 
Levels of D-lactate (A) and endotoxin (B) in the serum of mice. All group names correspond 
to those described in the legend of Figure 1. Data are shown as means ± standard deviations. 
The values of groups with different letters differed significantly in an ANOVA, followed by 
Tukey’s post hoc test (P <0.05). n = 6 mice per group 
Figure 3 Effects of administration of a mixture of Lactobacillus species (JUP-Y4) on the 
expression of mRNAs corresponding to the tight-junction proteins ZO-1 (A), occludin (B) 
and claudin-1 (C) in ileal and caecal tissues of mice. 
Gene expression levels are expressed as values relative to the control group. All group names 
correspond to those described in the legend of Figure 1, ( ) Control group (Cont), ( ) 
Ampicillin group (Amp), ( ) Natural Restoration group (NatR), ( ) Mixed Probiotics 
group (JUP-Y4). Data are shown as means ± standard deviations. The values of groups with 
different letters differed significantly in an ANOVA, followed by Tukey’s post hoc test (P 
<0.05) 
Figure 4 Administration of a mixture of Lactobacillus species (JUP-Y4) alters the diversity 
and structure of antibiotic-disturbed gut microbiota. 
(A) Shannon index of microbiota diversity from faecal samples of mice from different groups 
(α-diversity), * P<0.05, compared with control, ** P<0.01, compared with control, using 
Independent Samples t test. (B) Unweighted UniFrac PCoA plot, characterised by an 
abundance of diverse bacteria in samples. The first principal component (PC1) and second 
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principal component (PC2) respectively explained 28.27% and 10.92% of the variance in the 
unweighted UniFrac metrics. Each point represents the faecal microbiota from a single 
mouse. ( ) Control group (Cont), ( ) Ampicillin group (Amp), ( ) Natural Restoration 
group (NatR), ( ) Mixed Probiotics group (JUP-Y4). (C) Clustering of the group means 
based on the Mahalanobis distances derived from the PCA. All of group names correspond to 
those described in the legend of Figure 1. n = 6 mice per group 
Figure 5 Relative abundances of the main phyla after antibiotic exposure and restoration 
following administration of a mixture of Lactobacillus species (JUP-Y4). 
The abundances of microbial phyla in faecal samples (A) and caecum content samples from 
different groups (B). Data are expressed as means ± standard deviations. n = 6 mice per 
group. All of group names correspond to those described in the legend of Figure 1, the 
different colours of legends represent different phyla, ( ) Actinobacteria, ( ) 
Bacteroidetes, ( ) Deferribacteres, ( ) Firmicutes, ( ) Other, ( ) Proteobacteria, (
) TM7, ( ) Verrucomicrobia 
Figure 6 Heatmap analysis of the abundances of 40 microbial taxa in faecal samples from 
mice that were administered a mixture of Lactobacillus species (JUP-Y4) after antibiotic 
exposure. 
The abundance of a taxon is expressed by colour as indicated. All of group names correspond 
to those described in the legend of Figure 1 
Figure 7 Heatmap analysis of the abundances of 40 taxa in caecal content samples from mice 
that were administered a mixture of Lactobacillus species (JUP-Y4) after antibiotic exposure. 
The abundance of a taxon is expressed by colour as indicated. All of group names correspond 
to those described in the legend of Figure 1 
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Figure 8 Production of cytokines in the antibiotic-induced ileum, caecum and colon of mice 
that were administered a mixture of Lactobacillus species (JUP-Y4). 
The levels of cytokines measured were TNF-α (A), IL-6 (B), MCP-1 (C) and IFN-γ (D). All 
of group names correspond to those described in the legend of Figure 1, ( ) Control group, 
( ) Ampicillin group, ( ) Natural Restoration group, ( ) JUP-Y4 treatment group. 
Data are shown as means ± standard deviations. The values of groups with different letters 
differed significantly in an ANOVA, followed by Tukey’s post hoc test (P <0.05). n = 6 mice 
per group 
Figure S1 Effects of a mixture of Lactobacillus species on the expression of genes encoding 
inflammatory factors in the ilea and colons of ampicillin-exposed mice. 
Levels of mRNA of TNF-α (A), IL-1β (B), MCP-1 (C) and IFN-γ (D) in the intestines of 
mice. Gene expression levels are expressed as values relative to the control group. All of the 
group names correspond to those described in the legend of Figure 1, ( ) Control group 
(Cont), ( ) Ampicillin group (Amp), ( ) Natural Restoration group (NatR), ( ) 
Mixed Probiotics group (JUP-Y4). Data are shown as means ± standard deviations. The 
values of groups with different letters differed significantly in an ANOVA, followed by 
Tukey’s post hoc test (P < 0.05). n = 6 mice per group  
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